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Introduction
This report is intended as an ｩ ｮ ｴ ･ ｲ ｩ ｾ document, settinq
out as far as possible the current state of the argument on
multiphasic health screeninq and suqgestinq a course of re-
search that IIASA, given its in-house personnel and its
possibilities for contacts with other organisations, might wish
to follow. The literature survey in thefimt part of the study
cannot'lay claim to being complete (in so far as this is ever
possible), but it seems unlikely that any maior study has
been omitted which is likely significantly to alter the con-
clusions herein. This document is consciously structured as
a research prospectus and it is hoped to elicit comments to
it on this basis.
Definitions
The U.S. Commission on Chronic Illness (1) defined
screening as "the presumptive identification of ｵ ｾ ｲ ･ ｣ ｯ ｱ ｮ ｩ ｺ ･ ､
disease or defect by the application of tests, examinations
or procedures whicl1.can be applied rfilpid1y •••• 'A. screening test
is not intended to be diagnostic. Persons with positive or
suspicious findings must be referred to their physicians for diagnosis
and treatment." Further distinctions can be ｾ ｡ ､ ･ between
!!!!.!! screening and selective screening of "high risk" or
other groups and between one-shot screening tests (such as the
PAP smear for cervical cancer) and multiphasic screening which
normally includes "a medical history and physical examination
and a range of measurements and investigations (e.g. chemical
and haemato10gica1 tests on b10dd and urine specimens, 1ung-
function assessment, audiometry and measurement of visual acuity),
all of which can be performed rapidly with the appropriate
ff ' d ; t"sta .1ng an equ1omen. (2)
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In automated multiphasic
screeninq mechanical or electronic devices administer the
tests and the results or data are introduced directly or
manually into a computer which does all the necessary calculations
and records and analyses the results (3).
Altho\lgh the definition of screeninq quoted ahove stresses
the distinction between screeninq and diaqnosis, in practice
it is not always possihle to maintain such a riqid distinction.
A physical health examination carried out by a physician, for
example, will contain elements of hoth screening and diaqnosis
and ｾ Ｇ ｊ ｨ ｩ tBy has pointed out that .. another effect of the develop,
ment of high-capacity automatic lahoratory equipment has heen
to make availahle to doctors, for screeninq purposes, the
same investigations as are availahle to doctors for the
investiqationof patients. It is not always possihle, therefore,
to follm·, up an abnormal fincHnq revealed as part of a
screening ｰ ｲ ｯ ｾ ｲ ｡ ｭ ｭ ･ other than hy reoeating the same measure-
ment, this time as part of a diannostic procedure." (2)
tI'here has heen over the past few years a good deal of
thought given to the characteristics of an acceptable screening
programme, i.e. an attempt to set up a check-list of those
factors which are necessary (or perhaps only desirahle) for a
screening programme to he implemented. Although the utility of
such a check-list, or rather the way in which it is open to
misuse,is not difficult to ､ ･ ｭ ｯ ｮ ｳ ｴ ｲ ｡ ｴ ･ ｾ ｴ ｾ ･ one proposed hy
YAJi 1son nnd .Jungner (4), for example, probably encapsulates best
the thinking of epidemiologists on the evaluation of screeninq
procedures. It provides a handy measure against which to compare
the present state of multiphasic health screening.
'J'he l"lilson & ,Jnngner principles are
1. The condition heinq ｾ ｯ ｵ ｱ ｨ ｴ should be an important
health prohlem, for the mnividual and the community.
2. There should he an acceptahle, form of treatment for
patients with recognisable nisease.
3. The natural history of the condition,includinq its
developMent from latent to neclared nisease,should be
adequately understoon.
4. There ｾ ｯ ｵ ｬ ､ he a recoqnisahle latent or early sympto-
matic stage.
5. There should he a suitahle screeninq test or examination
for detectinq the disease at the latent or early
symptomatic stage and this test should he acceptable
to the population.
6. The facilities required for diaqnosis and treatment of
patients revealed by the screening proqramme should be
available.
7. There should be an aqreen policy on whom to treat as
patients.
B. Treatment at the presymptomatic, borderline staqe of
a disease should favourably influence its course and
proqnosis.
9. The cost of case-findinq (which would include the cost
of diagnosis and treatment) needs to be economically
balanced in relation to possible expenditure on Medical
care as a whole.
10. Case-finding should be a continuous process, not a
"once-for-all" proiect.
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History and Current Status
Thorner (5), in his critique of multiphasic screeninq,
suqqests that the concept of multiphasic screeninq for the
detection of disease was born in the period immediately after
World War II and after enjoyinq a brief flourish, appeared
to have died out by the end of the fifties. It revived aqain
in the mid-sixties, however, and had by the end of the decade
become once more a live issue in discussions of medical care
in the U.S. The notion of the periodic health examination
has n longer history having had its advocates even in the
nineteenth century. In 1922 the American Medical Association
House of Delegates approved the idea of periodic medical
examinations of "persons supposedly in health" (6).
Thorner attributes the first and second coming of multiphasic
screening to technical developments that made the ｴ ･ ｳ ｴ ｩ ｮ ｾ of
large numbers of people feasible by simplifying the test pro-
cedure and reducing the cost per test. The existence of large-
scale screening programmes for tuberculosis and syphilis after
World War II provided a ready-made bandwagon upon which other
tests could be placed e. g. for diabetes and led to the develop-
ment of a number of demonstration projects throughout the U.S.
By the end of the fifties most of these multiphasic screen-
ing programmes had failed, a failure which Thorner attributes
to the fact that the programmes were not properly integrated
into the existing medical care system. The programmes, which
were normally carried out by local health departments made
little or no provision for diagnosis, follow-up and treatment
and hence incurred the suspicion and resentment of private
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doctors who alleged that they "dumped large numbers of disease
suspects upon the private practitioners and provided no financing
or facilities for diagnosis and ｴ ｲ ･ ｡ ｴ ｭ ･ ｮ ｴ ｾ Ｂ
The periodic health examination which had traditionally been
confined mainly to executive and managerial employees of corpora-
tions had shown no similar decline but in 1965,forty years after
the A.M.A. statement, Grimaldi, having reviewed the various
reports on such programmes, was forced to conclude that the
question was still unsettled as to whether the examinations were
practical when their yield was weighed against the time, cost,
facilities, skill and energy required to provide them.
The development in the 1960's of multi-channel chemical
auto-analysers and computer techniques as well as increased
concern with chronic diseases led to a resurgence of interest
in multiphasic health screening. Faced with problems of
"physician shortage" relative to growing demands ｦ ｯ ｾ health care,
the prospect cf using methods which would allow automated techniques
and paramedical personnel to be substituted for expensive physician
time was clearly an attractive one. A number of large programmes
had continued in existence througout the period. Prominent among
them was the Kaiser-Permanente programme, where multiphasic screening
was embedded in a large prepaid health scheme. "This scheme
attracted particular attention due to the lead it provided in the
use of automated techniques.
A survey in 1969 by the u.s. National Centre for Health
Services Research and Development indicated that at that time ther.e
were about 150 Automated Mult±phasic Health Testing (AMHT) programmes
in operation in the U.S., the majority of them not receiving any
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form of governmental financial support (7).
In Sweden AMHT was used by a group of six non-medical pel'sarmel
to screen 89,000 persons in Varmland in the beginning of the sixties.
This was to be followed up by further research programmes culminat-
ing in the trial screening of an entire county (about 250,000
inhabitants) in 1974 (8).
A nwnber of small-scale trials have been. carried out in the
UoK.; Dotably by Scott and Robertson in Edinburgh (9), by Holland
and ｔ ｾ ･ ｶ ･ ｬ ｹ ｡ ｮ in London (10), and by Bennett and Fraser in Northum-
berland (11).
In Japan, the Toshiba Screening Programme provides an auto-
mated multiphasic health screening system for the 115,000 em-
ployees of ｔ ｾ ｳ ｨ ｩ ｢ ｡ Ｎ In 1970 it was the only one of its kind in
Japan. In Yugoslavia an ongoing collaborative project between
the American NCHSRD and a number of Yugoslav health agencies is
providing an experimental mUltiphasic screening programme in
Hontenegro.
Information on other examples of ｭ ｵ ｬ ｴ ｾ ｨ ｡ ｳ ｩ ｣ screening is
iraglnentary. In Austria a feasibility trial of a national multi-
phasic screening programme was carried out in Vienna and Carinthia,
in which 25,000 out of an invited 100,000 persons took part. The
scheme is now being gradually introduced on a nationwide basis.
A local scheme in Vorarlberg has also been reported, although its
iu-cure :celationship to the federal programme is uncertain.
It would therefore seem that ｭ ｵ ｬ ｴ ｾ ｨ ｡ ｳ ｩ ｣ screening, and
especially automated screening, is likely to become increasingly
a candidate for health service resources.
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The Case Against Multiphasic Screening
Much of the criticism of multiphasic screening (or the periodic
health examination) has centred on the fact that while such testing
discovers many abnormalities there is little evidence that such
discovery leads to a better prognosis for the patient. After re-
viewing a series of studies reporting the experiences of patients
who had undergone some form of early disease detection procedure
Thorner (5) concludes "The evidence adduced by these studies for
or against the effectiveness of multiphasic screening can hardly
be considered definitive." Although many studies showed some
improvement in morbidity and mortality of a tested group compared
with a "control" population, none of the studies represented a properly
designed randomised controlled trial and therefore considerable
doubt must always exist as to whether the "control" population was
really comparable.
Similarly Siegel in his review of the Periodic Health Examination
(11), observes that there is no proof that populations receiving
Periodic Health Examination (PHE) live longer, happier or healthier
because of it, nor is there proof to the contrary. "PHE rests on
the basic premise that discovering disease (or disease propensity)
in the asymptomatic stage permits favorable intervention. Doubt
is raised as to the validity of the premise as it applies to the
prevalent, significant American adult diseases." Siegel suggests
that if it is desired to persist with a policy of periodic health
examinations, despite the lack of evidence of effectiveness, the
,
policy should be modified to consist of the encouragement of Early
Sickness Consultation for the majority of diseases for which pre-
symptomatic detection is of no proven benefit. combined with
periodic selective mass screening campaigns, using little or no
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medical personnel, for the "relatively few amenable silent diseases."
He does not explore in any detail, however, the resource consequences
of the alternative programmes or the diff'iculties of encouraging
"early sickness consultation."
Sackett (12) cites the early results from the Kaiser-Permanente
trial of multiphasic screening as evidence'for the ineffectiveness
of such programmes. After several years of the programme these
investigations were unable to determine any favourable health effect
of the periodic health examination on women and only one group
of men between the ages of 45 and 54 showed differences in disability
and absenteeism. "Furthermore, these differences, while statistically
significant are clinically unimpressive--only 3.9 % less disability
and 1.3 % better attendance at work. The results of this study
are quite sobering."
Schor etaL. (13) in their examination of patients who had died
and who had previously received a periodic health examination
attempted to determine how often the examination had detected the
subsequent cause of death. This, of course, is quite apart from the
question of whether anything could have been done to prevent this.
He found that, in all, the subsequent cause of death was only discovered
in 51 % of the patients who died and the success rate was much
higher, ｮ ｡ ｴ ｵ ｾ ｡ ｬ ｬ ｹ enough, the nearer the PHE had been to the
patients' death. This suggests that not only had PHE only detected
about half of the causes of death but that, from the point of view
of intervention, the utility of even these discoveries would be
I I
much reduced by.the late stage at which they were discovered.
Furthermore a study of matched living counterparts indicated that
the same diseases that caused death were diagnosed with considerable
frequency in those who did not die. The problem of dealing with
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such ｾ ｡ ｬ ｳ ･ positives" or "borderline" cases is another recurring
problem in the evaluation of screening procedures.
A similar criticism is made by Sackett (12) who ｰ ｯ ｩ ｮ ｾ ｯ ｵ ｴ
that most victims of coronary attack do not have clinically abnormal
levels of serum cholestorol, blood pressure, triglycerides, uric
acids or other risk factors; the number' of victims with abnormal
values for these coronary risk factors, despite their higher
attack rates, are relatively few in number. Since, in his view,
"the treatment of abnormal levels for the most prominent of these,
blood pressure, does not appear to lower coronary risk, it must
be acknowledged that the treatment of risk factors is not likely
to have a profound impact upon the underlying burden of disability
and untimely death."
The application of multiple biochemical screening on a
routine basis came under fire from Ahlwih (14) and Barnett et ale
(15). While reiterating the criticism that little' evidence exists
about the ability of physicians to influence the course of many
of the abnormalities they discover through such screening, they
also point out the ambiguity of many of these biochemical measure-
ments from the point of view of clinical significance. Barnett
cites a study in which calcium analyses were carried out routinely
on approximately 12,000 patients. Since significance levels are
normally set at the 5,% level, approximately 600 were deemed to
have abnormal results. The analysis is detailed in Table I.
-JO-
'!'able !
Results and Follow-np of Poutine CalcillJll }\nalyses
Number of Patients 11,991 (100%)
Abnormal 600 (5%)
Significantly Abnormal 21 (O.:u%)
% of abnormals 3.8%
Other not siqnii:icant 539 (4.8%)
% of abnorJllals 9fi%
Diseases Found 23 (0.23%)
Diseases Treatable 14 (0.14%)
Source: Barnett et al.
Barnett points out that the discmrery of these 14 diseases
necessitated additional studies of 600 people, 571 of whom. qave
abnormal results because of laboratory errors, known diseases
or for no re?ison ever found, and ohserves that "the amount of
harm done to the 577 persons is not measured."
A point made by both Ahlwin and Barnett is. that since
biochemical tests are, in general, desiqned so that 5% of the
results are termed abnorrnal, a screening ｰ ｲ ｯ ｧ ｲ ｡ ｾ ･ involvino a
combination of tests administered simultaneously is likely to lead
to a scol:eof "abnormals" well in excess of 5%. In a situation
where 12 constituents are measured one would expect that over
half the patients would have at least one abnormal value and many
of these will require follow-up and confirmatory tests. 'T'his
leads into the question of the iJllpact on the health care system
of such screening.
Many critics have sugqFsted that ｩ ｾ is very unlikely either
that over-stretched health services in the U.S. and Fourope could
provide sufficient manpower and facilities to carry out such
testing or that the system could cope with the necessary ｦ ｯ ｬ ｬ ｯ ｷ Ｍ ｵ ｾ
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diagnosis and treatMent which the finding of such cases wouln
imply. To the extent, of course, that Multiphasic screeninq
prevented a significant number of chronic diseases then in the
longer run such screening miqht reduce, the demand mane hy such
diseases on the health services. In the short run, however,
it would seem likely that such screening programmes wouln impose
a net additional burden. Even in the longer run, it miqht
well be that early detection lean to the patient requiring long-
term maintainence therapy for an otherwise fatal disease, a
result which, however, desirahle in itself, is unlikely to
lead to a reduced use of health services. On the basis of the
preliminary results of the Kaiser-Perrnanente study, Thorner
discerns an excess in the use of outpatient facilities hy those
patients receiving more screening tests over the "control"qroup
of patients. ' The evidence, however, for this effect is limited.
One final problem with multiphasic screening may be noted
and that is the reaction of physicians to the information pro-
vided. Bates and Yellin (16) found for only three out of 15
tests administered by a multiphasic screeninq programme did
the patient ',S own physician carry out a confirmation more than
half the time. When reasons for not doing so were examined,
it was found that in over one-quarter of the cases this was
because the results were either horderline or were unaccompanied
by clinical manifestations. Bates & Yellin suggest that this
is largely because of the high prohahility that the results
would turn out to be a false positive in cases of niseases with
low prevalence and that such unwillingness may therefore be
quite "rational" but, of course, such behaviour necessarily
reduces the utility of the screening programme.
Barnett"cites a study in which screening profiles were
carried out on an unsolicited basis for 400 patients. These
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results were later presented to the attending physician after
the patient was under ｴ ｲ ｾ ｡ ｴ ｭ ･ ｮ ｴ and the tests were scoren on
the hasis of whether they were helpful, a hindrance (in the sense
that they led to further fruitless studies), or neither a help
nor a hindrance.. ｾ ･ ｳ ｴ ｳ reqarded as a hindrance occurred
eight times as often as tests reqarded as helpful.
The Case for Multiphasic Screeninq
Proponents of Multiphasic screening (or periodic health
examinations) rely on two sorts of arqUJllents. The first attempts
to sh0''1 that such procednres are, in fact , effective, in the
sense that they do lead to a reduction in disability, time-off
work and ll'l.ortali ty and that they do not involve an excessive
hurden on the health service.. The second araument is that
Multiphasic screeninq is an essential eleMent in a new system of
medical care which ouqht qradually to replace the present system.
ｇ ｲ ｾ ｮ ｡ ｬ ､ ｩ Ｌ after a review of previous ｳ ｴ ｵ ､ ｩ ｾ ｳ of PRE which
,were largely inconclusive as to henefit, analyses data for three
qroups of General F.lectric workers. One qroup consisted of a
random saIl'\ple of Middle Manaqement employees at a particular nlant
who had volunteered for a routine 'PHE \'lhich the company had heen
offerinq for many years.. 'T'he second""qroup was a rannom sample
of non-participants and the third a similar group of employees
from another plant where 9.lch examinations were not made availahle
by the company. '!'he groups were then compared on the basis 6f
medical and surgical expense claims suhmitted to the cOMpany's
insurance plan for a period of eight years.
The results were as follows:
1 .. 'l'he number of nedical insurance claiTr'\s per examineil
claimant increases with the time between examinations.
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2. The smallest ｮ ｵ ｾ ｨ ･ ｲ of claims occurs during the year
of exmnination.
3. The difference between the examined and unexamined,
with respect to the average number of claims for
claimant is ｮ ･ ｱ ｬ ｩ ｾ ｩ ｨ ｬ ｹ small.
4. The medical expense per ｣ ｬ ｡ ｩ ｾ ｡ ｮ ｴ increases as the time
hetween examinations increases.
5. The average claim is qreater for the unexamined and
the difference tends to exceed sionificantly the cost
per PRE and, in addition, occasions for ｰ ｡ ｹ ｾ ･ ｮ ｴ for the
treatment of coronary heart disease, circulatory dis-
orders, Maliqnancies ann diabetes in the unexamined
sample were somewhat hiqher than in the examined.
These results would appear to answer some of the questions
raised by the, critics of multiphasic screeninq and PHEs. In
particular, the burden imposed upon the health services hy this
scheme would not appear to be qreat and there is, indirect evidence
of a consequent reduction in morhidity. It should he noted,
however, that the study qroup volunteered to take a PHR while the
controls either did not or could not. 1n this sense the groups
may not be strictly comparable. It should also he noted that
Griwaldi is principally interested in whether PHRs are a pro-
fitable activity from the firm's point of view. The lower
health care expenses may simply represent false reassurance and
do not tell us anything about eventual Mortality. Finally, the
caveat of Thorner should be borne in ｭ ｩ ｄ ､ ｾ Ｎ After suqqesting
that the success of screeninq appears to be related to the
Inedical care services already available to the population, he
points out that in a study among persons in the lower socio-
economic group with poor access to medical care and presumably
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poor follow through after screeninq, fue examinations seemeo to
make little differenceo
Roberts et aL (17) compared the mortality experience of a
large group of patients who had underqone one or more PHE!=; with
that of groups of the UoS. population. In particular, given the
socio-economic make-up of the study group, they compared the group's
experience with that of professional, technical, administrative
and managerial workers among the white, male population. Using
this latter comparison, the mortality ratios of the study popula-
tion were appreciably less than 1.0 in each catesory for which
comparable U.S. data were available.
The Commi9ion on Chronic Illness conducted a mUltiphasic
screening in Ral tiTllore in 1954. subsequently a follow-up study
was carried out twelve years later (18) 0 ｾｨ･ study showed that
screenees and especially female scrp.enees had a better !=;urvivor-
ship than did individuals who had refueed screeninq and these
differences persisted after ｡ ､ ｪ ｵ ｳ ｴ ｾ ･ ｮ ｴ for social class and
for variations in history of chronic diseases or disahility
at entry to the study 0 Hmvever, in only one of the 14 aqe,
race, sex combinations din. the confidence limits for death rates
fail to overlap, namely white WOMen aqed 40-49. Once aqain the
problem of participation bias also affects the interpretation
of the results.
The Kaiser-Permanente.Herlical Group, which was one of the
pioneer!=; of multiphasic screeninq, has heen carryinq out a trial
of the procedure sillce 1964 (19) (20). The study qroup consists
of a random sample of meIllbers of the Health Plan who have been
encouraged to take advantage of the periodic multiphasic
screeninq offered to all memhers, while the main control uroup
consists of a randoTll sample of Inembers who have not been so
-lS-
･ ｮ ｣ ｯ ｵ ｲ ｡ ｧ ･ ｾ 0 ＧｾＧｨ･ study qroup ha0, after the initiill perioo,
annual exaHination rates of 60% - 70%, while the rates for the
control group were Ｒ Ｐ ｾ - ＲＴｾＮ Seven years ilfter the initiation
of the urqinq effort, the averaqe cUJTlulated numher of multiphasic
health checks per suhi ect was 3 050 in the stl10y group ilnd 1. 3
in the control group. Ｑ Ｗ ｾ Ｌ of the study group had no examination
during the period compared ",lith 479.; of the control group.
Analysis of the, data ｴ ｨ ｲ ｯ ｵ ｾ ｨ 1970 showen the following
principal results:
1. 'J'here '>!Jere no siqni ficalll: study-control group differences
in utilisation of outpatient serwices, i.e. no over-
whelminq demand for additional outpatient services seems
to have been neneraten by the increase0 study group
exposure to Multiphasic Health Checks, nor has there
been a notable reduction in utilisation o
2. In one of the four aqe-sex qroups (men aqed 45-54) a
significantly higher rate of self-reported disahility
elllerged after five years and persisted in the followinq
bi-annual survey. In the other three qroups (men and
women aged Ｓ Ｕ ｾ Ｕ Ｔ Ｉ no significant difference had appeared
after seven years.
3. There were no statistically siqnificant difference in hos-
pital utilisation hetween the stndy and control groups,
although towards the end of the period utilisation rates
appeared to he consistently higher-among older control-
group males' and lower among females o
4. Causes of death ｡ ｊ Ｑ Ｑ ｯ ｮ ｾ study and control population were
divided,before the results were known, into twoclasses,
a class likely to he reduced in persons takinq periodic'
Jnultiphasic checks and a remainder grmlP. 'T'he results
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are set out in tahle 2.
'T'able 2
neath and Death Rates 7\I"\onQ Study
Death
Study Control
and Control nroups 1965-71
Death Rates Chi-Square
Study Control Value
Potentially Post-
ponable Causes
Other Causes
All Causes
* p ＨｾＰＲＵ
J9
164
183
41
176
217
3.7
31.9
35.6
7.4
31.8
39.2
6.55*
0.00
0.95
Source: Dales et al.
ｊ ｾ ｲ ｯ ｭ this it can be seen that the class of deaths labelled
"potentially postponahle" was significantly smaller among the
study group population, the greatest contribution to the difference
being attributahle to cancer of the colon and rectml'l and hyper-
tension-hypertensive cardiovascular disease.
A study of screening by general ｰ ｲ ｡ ｣ ｴ ｩ ｴ ｩ ｯ ｾ ･ ｲ ｳ in the U.K.
by Bennett allowed him to estimate that the extra consulting
tilne occasioned by the screened qroup (apart from the time
required for the screening itself). was ahout 10%. ,Jungner and
Jungner, in their Vaermland study (21} report on the disposal
of screening subjects to the health care system. ｾ ｢ ｯ ｵ ｴ 4% of
those screened were referred to a doctor for diagnosis and about
0.3% were hospitalised. They reJnark that "this figure contrasts
sharply with the fears of SOMe advisors before the screening
started." 'l'he significance of the fiqures is, however, difficult
to inte:r:pret in the absence of measures of effectiveness.
'J.'he second line of advocacy of JllUltiphasic screening sees
it as the basis of a new method of orqanising health care which
will move the focus of health care from treatment of ｳ ｾ ｰ ｴ ｯ ｭ ｡ ｴ ｩ ｣
-17-
disease towarns prevention bV the use of paraMedical personnel
and ､ ･ ｶ ･ ｬ ｯ ｰ ｾ ･ ｮ ｴ ｳ in medical technoloqy. Garfield (22), for
example, sees automated health testinq as providina a means of
regulatinq entry into the health care system which is fairer
and more efficient than the pricinq system. "Much of the
trouble with the existinq delivery system derives ｦ ｲ ｯ ｾ the im-
pact of an unstructured entry ｾ ｩ ｸ on scarce and valuable doctor
time. Health testinq can effectively separate this entry mix
into its basic ｣ ｯ ｾ ｰ ｯ ｮ ･ ｮ ｴ ｳ Ｚ ｴ ｨ ･ healthy, the ｳ ｹ ｾ ｰ ｴ ｯ ｾ ｬ ･ ｳ ｳ early
sick and the sick. ｾ ｨ ｩ ｳ clear separation is the key to the
rational allocation of needed medical resources to each qroup ••••
The clear definition of a health care service, made possible
by health testinq, is a basic first step towards a positive
program for keepinq people well •••• Whether or not one helieves
in the possibility of actually keepinq people well, however,
is now beside the ｰ ｯ ｩ ｮ ｴ ｾ this new health-care service is
absolutely essential in order to meet the increasinq demand for
just this kind of service and to keep people from overloading
sick-care resources."
Shapiro (23) puts it like this, "Initially A.M.H.'T'.'s qoal
was to aid in the detection of previously unknown disease. This
has been expanded to include identification of patients with
high risk for development of chronic disease and the initiation
of health education to ｾ ｯ ､ ｩ ｦ ｹ personal practices associated with
adverse risk." The extent to which health testing can alter
patients' behaviour in the lonq run is still unknown.
There would also appear to be certain amhiqllities in the
notion of health-testing as a requlator of entry into the health
care service. Garfield ｡ ｲ ｾ ｵ ･ ｳ that fees act as a deterrent to
use of the service, but that some other requlator is necessary
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and healfutestinq could act as this reaulator. ｾ ｨ ･ ｾ ｡ ｩ ｳ ･ ｲ ﾭ
Permanente A.M.H.T. procedure lasts, however, somewhere be-
tween two and three hOur.s, quite apart from any travellinq and
Waitina tiMe. Since individuals have tiMe as well as money
budqets, it would seem likely that this bTO to three hour time-
expense would also act as a deterrent. That it does so is,
perhaps,evidenced hy the fact that despite the screenina pro-
cedure heinq a money-free service to Memhers of the Pealth Plan,
only ahout 20% of meJTlDerS actually take advantaae of it in
a norr'1al year. Fven "'Then a saMple of Mf:'Mhers were suhj ected
to intensive encouraqement to take part, 17% did not do so
once durinq a oeriod of seven years. r.·Thether such time-
prices are a fairer way of requlatinq entry into the system
than Money-prices could oresl1mahly he decitied if infOrMation
existed on the type of people discouraqed. hy either method.
There seems no a priori reason, however, why time-price reau-
lation shoulrl reaulnte entry More in.]ine with "need" than Money-
price regulation.
Multiphasic ｾ ･ ｳ ｴ ｩ ｮ ｡ nnti the Health Care ｾ ｹ ｳ ｴ ･ ｊ ｔ ｬ
Questions ahout the place of multiphasic test ina in the
heal th CRre, systeln have received a lot of attention and it has
heen frequently suqqested thRt unless multiphasic testinq is
properly inteqrated with the rest of the health care ｳ ｹ ｳ ｴ ･ ｾ
it will not succeed. Clark nnd Ariet (24), after reviewing
successful AMHT set-ups, rank intearation within the local
health delivery system as their condition for success.
By "inteqration" is meant that fue testing should operate
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within a system of health care which provides for follow-up,
diagnosis and treatment and that it should operate through,
or with the cooperation of the patient's personal physician.
Related to this is the provision that sufficient resources should
exist to ensure that the results of the screening are acted
upon where necessary. Otherwise there is the danger that, as
Bates and Yellin discovered, many patients will not be seen by
their physician following screening. "The complexity, dis-
continuity and fragluentation of medicdl care complicated by
patients' misunderstanding, took their toll. This emphasizes
the iluportance of close collaboration between screening unit
and medical care system."
Some authors have suggested that the institution of AMHT
is bound to fail unless health care delivery systems are re-
organised so that doctors operate from large prepaid group
practices which could afford, or justify, the capital invest-
ment and paramedical personnel required for Automated Multi-
phasic Health Testing and yet provide the continuity of care
required (25) (26). It is also claimed that unless such a
reorganisation takes place multiphasic health testing will not
reach the medically underprivileged.
On the other hand the schemes currently in opera lion in
Austria and Great Britain rely on general practitioners to carry
out the screening procedures and, in general, imply no radical
alteration in the structure of health care delivery.
Costs and Benefits
Very few studies exist which attempt to estimate the costs
and benefits of early disease detection, a fact which is hardly
surprising given the paucity of data on the outcome of screening
- 20 -
programmes. The study by Grimaldi mentioned already claimed that
the excess of health insurance claims of an unscreened population
over a screened one more than offset the cost of screening such
a population.
The Kaiser Permanente study found only one of its four age-
sex groups where disability, hospitalisation and mortality trends
were all in the same direction (favouring the study group), namely
the group of men aged 45-54 on first entry. The direct (medical)
costs and indirect (income loss) costs associated with screening,
outpatient services, hospitalisations, self-reported disability
and mortality were computed and compared for the older men in
the study and control groups. For this group the net "savings"
favoured the study group older men every year during a seven-year
period and was more than $800 per man entering the project in
1964, in favour of the study group, for the entire seven-year
period. This sort of measure is, of course, open to the usual
reservations about the use of income loss figures as ｭ ･ ｾ ｳ ｵ ｲ ･ ｳ
of benefit.
A rather different impression emerges from a remarkable study
by Forst (27) in which he analysed data from Periodic Health
Examinations given to Navy and Army officers. Because of
differences in the scope and frequency of PHEis between the two
armed services he was able to make estimates of the cost and
morbidity effects of changes in the scope and frequency of PHE's.
He estimated that a shift from a strategy of givirig a PHE worth $25
once every three years to that of giving one worth $100 annually
could be expected to prevent about seven officers out of each
10,000 from joining the rolls of disabl·ed retirees annually. Such
a shift would cost $150,000 per head.
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When this sum was compared with the cost of retirement
benefits plus the cost of replacing officers retired with dis-
ability it was found that a replacement cost of $130,000 would
be necessary to make these two costs exceed $150,000. The likely
replacement cost was estimated to be less than one-fifth of
$130,000. The data and assumptions in ｴ ｨ ｩ ｾ study, as well as some
of the regression relationships estimated, make one treat the
results with caution but in sophistication and rigour it far excels
any other study, although the sophistication and rigour may well
be a product of the initial data problems.
A number of costing studies have been carried out by the
Kaiser-Permanente workers (28) (29). They estimated that for
1967/68 the cost per automated multiphasic screening test at their
Centre was $21.32, based on a monthly total of 2000 patients. They
believed this cost to be four to five times less than the cost
of providing an equivalent screening by non-automated methods.
They also estimated that there was significant economies of scale
in automated screening and suggested, for example, that if the
number of patients were to rise to 3000 per month the cost might
fall to $15 per screening.
Estimates were also made of the cost of detecting various
abnormalities by multiphasic screening. These costs ranged
from $408 for a suspected breast cancer to $1.55 for an apparent
hearing defect. No estimates were made of the cost of confirming
such presumptive cases.
There are some points to be made here. The costs estimated
by Collen and his co-workers refer to the personnel and equipment
for the multiphasic centre. They do not include any estimate
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of patients' time. The Kaiser-Permanente multiphasic schedule
takes up to three hours. If patients' time is valued on a
marginal productivity basis using an average wage rate of $10,000
per annum, then such a valuation would effectively double the
reported cost of multiphasic screening.
Secondly, as Collen pointsout, no analysis has been carried
out "comparing the cost of multiphasic screening technics to
alternative traditional methods for providing periodic health
examinations." Austria has opted for a fairly traditional method
relying on a primary physician and the costs do not appear to be
regarded as excessive. Nor would there seem to be any analysis
comparing the cost of adding extra tests under both systems.
Finally, very little has been said about the speed with
which a multiphasic programme could be introduced given its large
demands for personnel and facilities. Gelman (30) points out
that to carry out annual periodic health examinations for the
entire u.S. population, based on an estimate of 60 to 65 "family
service" physicians per 100,000 population available for diagnostic
services, each physician would have to perform roughly seven
physical examinations a day. As she says "Who would then care
for the sick?"
Conclusions
1. Multiphasic Screening or Periodic Health Examinations
still appear to be seriously deficient when assessed against the
checklist suggested by Wilson and Jungner. In particular it
is not fully established that treatment at the presymptomatic
borderline stages of the "diseases" discovered)favourably influence
their course and prognosis. Moreover it is not certain that the
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facilities requirer. for ｮ ｩ ｮ ｎ ｮ ｯ ｾ ｩ ｳ ana treatMent of patients re-
ｶ ･ ｡ ｬ ･ ｾ hy the screeninq proararnMe ｷ ｯ ｵ ｬ ｾ he availahle ｡ ｮ ｾ that
case-find ina in a aiven health care system wouln he a contin-
uous process, anc'l not a "once-anc'l- f'or ,all" proiect.
A numher of proiects are qoinq on, in andition to the
Kaiser-Permanente one,to assess the eff'ects of' multiphasic
sc:r."eenina (25), hut until these proiects have proqressed rurther,
it is difficult to say whether the cost of case-findinq (ne-
fined in as comprehensive a manner as possihle) would he
econOlllically balanceo in relation to possible expenaitllre on
ｊ ｾ ｰ ｲ ｬ ｩ ｣ ｡ ｬ care as a whole, since such a ｾ･｣ｩｳｩｯｮ could only be
taken with reference to the henerits of multiphasic screeninq
relative to possihle expenaiture on ｭ ･ ｾ ｩ ｣ ｡ ｬ care as a whole.
2 ｾ JVlnl tiphasic Health '1'estina can he viet"en in two c'li fferent
liqhts: (a) as a 1l1ultiple screenina proqraMme or (h) as the hasis
of un ill ternati ｖ ｴ ｾ Il1ethoc'l of deliverina primary care 0
Viewed in the first li0ht, the important question becomes
"Is HlUltiphasic screening worth doinq, in the sense that the
ｯ ｵ ｴ ｃ ｏ ｊ Ｑ ｬ ｅ ｾ of Multiphasic screeninq represents a more nesira.hle use
of limited medical resources than other proaramrnes?
ｾ Ｌ Ｗ ｩ ･ ｷ ･ ､ in the seconil liaht, the crucial question May '<Tell
be "T'lhat wouln he the effect on ｰ ｮ ｾ ｳ ･ ｮ ｴ hea.lth care systems of
an extension of the practice or Pll11tinhasic screeninq?" Bv this
is meant not simply 'Vlhat resources wouln. he ｲ ･ ｱ ｵ ｩ ｮ ｾ ｡ Ｌ but how
would the pattern of health care utilisation alter as "nrevention"
heealoe a ｉｮｯｲ｣ｾ important charrtcteristic of nriT'1ary care, what
chancres would he likely to eOTf'lp nbout in the way in which primary
health care was supplied ann how woulo this aff'ect other sectors
of health within a limiten hudqet. ｾ ｵ ｣ ｨ effects Jlliqht he ex-
pected to vary rlepenc'linq upon the ｾ Ｌ ｡ ｹ the prOqramMe was orqanisen.
-/.4-
3. There is very little in r oT.1'1at.ion availahle, aoparently,
on a nm"heT of topics. 'T'he CTRPS Hhich appeRT JTlost evident to
JTle are
(a) 'T'he lack of any systematic analysis or the ｾ ｩ ｦ ｦ ･ ｲ ･ ｮ ｴ
orqanisationa 1 structures throuqh to!hich JTlul tinhasic
screeninl1 is ｣ ｵ ｲ ｮ ｾ ｮ ｴ ｬ ｶ heina carrien out. .,.., fOrJ'Tlrtl
structure to clrtssify schemes hv pavJTlPnt mechanism,
physicicm participation, relationship to hospital, role
of puhlic henlth services, 0PfTrpe or autoJTlation, loc-
ation and so on is Missina and, especirtlly for Purope,
the data to flesh out the fOrJT'lal structnre is also
absent.
(h) nata on hm.! JTluch ｳ｣Ｚｮｾ･ｮｩｮｱ qoes on in a ｱｩｖｦｾｮ health care
system is difficult to COJTle hy. nf course, any precise
estilllate would oeoend on distinctions JTlaoe hetween
screeninq and diaonosis. Npvertheless, judqements about
the imnact of 1..,ul tiphasic screeninq JTliClht '''ell oepend
on the i:1JI,ount of screeninq qoinCT on outside such pro-
qramJTles (e.q. routine testinq ,of hospital patients,
expectant mothers, life-insurance candidates, specialist
professions, etc.) and ahout trends in such activities.
4.. 'rhere would appear to he SOJTle dispute ahout the possibilities
of insertinq a JIlultinhasic screeninq proqraJTlJTle into a health care
systel'l "Tithout iilUkinq ractical chancres in the system.
S. 'J'he work on costinq Which has been carried out has been
ve:ty limited and has qenern11y not addressed i tsel f to the totRl
sysi:eln f i .. e .. achievinq participation, screenimf, Datient time,
fo110\'1-up, diaqnosis and treatment. Nor has there heen any
atteNPi: to assess the effects of adninq or subtractinq tests or
a1terinq the adJIlinistration of the proqrarl1me. Tn short, there has
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been little costing of alter.natives.
Research Proposals
I set out below a list of ｰ ｲ ｯ ｩ ･ ｣ ｴ ｾ that IIASA miqht carry
out. It is not intended, necessarily, that all of them should
be done and the choice should take place in consultation with
interested parties such as hTHO, the health ministries of
meJT'her stotes or other orcranisations connected with health
care.
!=:urvey
A. sine quo non for any further work is a survey of ,,,hat
programmes, nescribed as "multinhasic screeninq", are currently
beinq carried on in a numher of countries, hoth Fast and Nest.
()ur aim should be to character.ise them hy a numher of relevant
variahles. \,1arshaw (3 ) sets out a nur.lher of. "onestions to be
answered" in decidincr whether to oraanise a multiphaRic screenina
programme. Ruitahly amended, these questions would form the basis
of a scheme of classification. ｾ ｮ additional important piece
of ｩ ｮ ｦ ｯ ｾ ｡ ｴ ｩ ｯ ｮ would be the sorts of data which the proqrarnmes
themselves collect and the extent to which this data is available
in treated or untreated form.
The bases for classification would be
1. Target Populations and Diseases
2. Financing
3. Number and Location of Screening Clinics
4. Manpower
5. Selection of Tests
6. Volume of tests carried out and participation rates
7. Provision for follow-up, diagnosis and treatment
8. ｾ ｡ ｮ ｡ ｧ ･ ｭ ･ ｮ ｴ of the Scheme
9. Cost of the Scheme
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Most of these classifications are fairly self-explanatory.
Financing refers to the inclusion or exclusion of such ｳ ｣ ｾ ･ ･ ｮ ｩ ｮ ｱ
programmes in relation to ｾ ｯ ｣ ｩ ｡ ｬ Sp.curity proqrammes, public
health programmes, etc. and the extent, if any, to which patients
must pny. Manpower refers to the relative use of medical and
non-medical personnel. Manaqement of the Scheme is intended to
elicit information about the relationship between the screeninq
programme and other health care services in addition to that
provided by No.7.
Some of this information may already he qathered for the U.S.A.
by the National Center for Health Services Research and Development.
For other countries, it is difficult to know even whether such
programmes are in existence.
I would suggest such a survey, in effect as a form of
feasihility study.
Health Service Impact
So far them has only been limited work on what effect the
introduction of a multiphasic screening proqramme might have ｯ ｮ ｾ ｴ ｨ ･
existing system of medical care, and how this ef.fect might be
related to the type of programme. In general, the worst fears
of those who opposed such programmes, namely that the existing
health care system would be swamped by large numbers of the
crypto-ill does not appear to have been borne out. There has,
however, been little analysis of why this is so. Were the critics
simply wrong i.e. there are not large numbers of slightly unwell
people or are there other explanations? Is it that the ｾ ｣ ｣ ･ ｰ ｴ ｡ ｮ ｣ ･ Ｂ
level was simply set at a level such as to ensure that there would
be little impact on the health service, or were health service
facilities already so strained that, in effect, a form of
rationing ensured that the screening programme was not allowed
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to make a major impact? The answers to these kind of questions
would require close analysis of the experience and criteria of
a number of screening programmes.
A related question is the way in which the institution of
such programmes affects the use of primary care facilities, out-
patient services and so on under various forms of health care
organisation. Does the pattern of demand for physician's services
and the use by the physician of, for example, laboratory facilities
change? The data for such a study might be available from records
of Social Security sickness claims,hospital records and so on.
Modelling Alternative Multiphasic Screening Programmes
Choosing a multiphasic screening programme implies some
knowledge or prejudice concerning the effects of alternative
strategies. As yet, however, there has been no attempt to construct
a model which would predict both the yield of alternative multi-
phasic screening programmes and the costs of such programmes.
Such a model would require, in the first instance, estimates
of suspect and confirmed abnormalities for a range of individual
tests and combinations of tests over time tpgether with data on
the proportions of confirmed populations likely to undergo various
forms of treatment. This would enable one to make estimatesof the
consequences in terms of cases discovered and effects on the health
care system of adding an extra test or set of tests to the programme.
It would also require estimates of the resources used up to
supply a given set of tests and the marginal costs of adding extra
tests to the range, as well the health care resources required
for follow-up and treatment. Added variables here could be the
organisational structure, the use of medical and non-medical
personnel, of automated equipment, different types of clinic and
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so on. It might also be possible' to derive estimates of the inter-
action between organisational characteristics of the screening pro-
gramme and the participation rate of the target population.
The data for such a study, or at least parts of it, should be
in the possession of screening programmes. To move from this partial
analysis of the effects of a screening programme to a comprehensive
analysis or a cost-benefit analysis would require estimates of the
effect of multiphasic screening on morbidity. The evidence for this,
as has been said, is still inconclusive. But even with the partial
model it should be possible to elicit estimates of the impact of
a screening programme by making (probabilistic) assumptions of the
effect of early discovery.
This proposal would overlap with the previous one but would
not attempt to trace the effect on the health services in general
of a multiphasic screening programme nor to concern itself with
the impact of individual programmes.
Case Studies
The introduction or adoption of multiphasic screening or
periodic health examination programmes takes place within a given
social and institutional setting. The programme might be expected
to affect some or all of the following: the target population, the
population in general (in so far as the programme reduced expenditure
on other health services or implied higher taxation or social security
contributions), the medical profession, both in the community and
in hospitals, public health administrations, health insurance in-
stitutions, manufacturers of relevant equipment.
Where such programmes have been introduced the choice of programme,
its administration and so on are likely to have been as much
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the consequence of the constraints represented by these various
groups as of the benefits and costs of the screening programme
itself. An analysis of the proposals, attitudes and reactions
of these groups in relation to a specific screening programme
might be expected to throw light on some of the constraints operat-
ing on the introduction of such screening programmes. Many of these
constraints would, of course, be confined to particular settings
but the attitudes of groups should also be found to have certain
general characteristics.
A useful starting point might be an analysis of the introduc-
tion of the Austrian multiphasic screening programme.
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